Susan Molineaux is at it again Weeks after biotech closes, she lands as CEO of cancer drug startup
| CALADelisted Stock | USD 0.05 0.00 0.00% |
About 56% of Calithera Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Calithera Biosciences pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Calithera Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Calithera Biosciences stock news signals to limit their universe of possible portfolio assets.
Calithera |
Susan Molineaux, former CEO of Calithera Biosciences and the CEO of startup Para Therapeutics
Read at bizjournals.com
 |
Calithera Biosciences Fundamental Analysis
We analyze Calithera Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calithera Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calithera Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Calithera Biosciences is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Calithera Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calithera Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Calithera Biosciences could also be used in its relative valuation, which is a method of valuing Calithera Biosciences by comparing valuation metrics with similar companies.
Peers
Calithera Biosciences Related Equities
| VSTM | Verastem | 16.85 | ||||
| HEPA | Hepion Pharmaceuticals | 4.69 | ||||
| ADVM | Adverum Biotechnologies | 2.95 | ||||
| CKPT | Checkpoint Therapeutics | 2.57 | ||||
| LPTX | Leap Therapeutics | 2.05 | ||||
| PDSB | PDS Biotechnology | 1.86 | ||||
| KOD | Kodiak Sciences | 1.83 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| MREO | Mereo BioPharma | 1.40 | ||||
| ABEO | Abeona Therapeutics | 0.31 | ||||
| GLMD | Galmed Pharmaceuticals | 0.35 | ||||
| ARDX | Ardelyx | 0.35 | ||||
| AFMD | Affimed NV | 1.05 | ||||
| ADAP | Adaptimmune Therapeutics | 1.37 | ||||
| PIRS | Pieris Pharmaceuticals | 3.45 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |